CSBR लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (25 Jun 2024 @ 01:30):
Our systems believe the stock currently is overvalued by -0.22% compare to its pairs and should correct downwards.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States...

Stats
आज की मात्रा	21
औसत मात्रा	7 453
बाजार मूल्य	67.15M
EPS	$-0.190 ( Q3 \| 2024-03-15 )
अगली कमाई की तारीख	( $-0.160 ) 2024-07-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.86 (Sector) 42.63 (Industry) 24.32
ATR14	$0 (0.00%)

AADI -2.94%

ABCL 1.65%

ABCM 0.04%

ABEO -2.84%

ABIO -1.68%

ABOS 1.64%

ABSI 2.89%

ABUS -2.29%

ABVX -3.53%

ACAD -0.71%

ACER -17.95%

ACET -4.12%

ACGN 1.29%

ACHL -3.00%

ACHV -1.61%

ACIU -1.00%

ACLX -0.04%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.91%

ADGI 0.87%

ADIL 0.54%

ADMA -2.68%

ADPT -0.30%

ADTX -3.47%

ADVM -3.91%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.82%

AGIO -2.06%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.46%

AKRO -2.89%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -2.29%

ALGS -2.41%

ALKS -0.19%

ALLK -9.32%

ALLO -6.24%

ALLR -3.32%

ALNA 3.16%

ALNY 1.81%

ALPN 0.02%

ALPX 0.00%

ALRN -0.33%

ALT -9.58%

ALVR -0.56%

ALXN 0.00%

ALXO -10.96%

ALZN 4.78%

AMRN -0.31%

AMTI -3.13%

ANAB 0.46%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.66%

ANPC -3.15%

APGE -0.91%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.00%

APLT -5.41%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 3.27%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.90%

ARDS -14.23%

ARDX -0.75%

ARGX -0.79%

ARNA 0.00%

ARPO -0.90%

ARQT -0.52%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.63%

ARWR -1.67%

ASLN -4.98%

ASMB -7.14%

ASND -0.94%

ATAI -1.48%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 3.40%

ATRA -2.21%

ATXI 1.93%

ATXS -1.00%

AUPH -1.17%

AURA 1.17%

AUTL -1.72%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -5.48%

AVTX -1.25%

AVXL -2.72%

AXLA 0.00%

AXSM -1.99%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.94%

BCAB 1.95%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 7.14%

BCRX 1.32%

BCTX 7.65%

BCTXW -16.32%

BCYC 1.10%

BDRX -3.52%

BDTX -0.43%

BEAM 0.49%

BFRA -2.91%

BGNE -2.72%

BIOR -3.40%

BIVI 2.50%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.71%

BMEA -9.88%

BMRN 0.34%

BNOX -2.22%

BNTC -2.11%

BNTX -1.47%

BOLD -8.11%

BOLT 1.31%

BPMC -1.27%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 22.88%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.62%

CADL -1.05%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA 0.21%

CARM 12.17%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.89%

CCCC -5.22%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.41%

CDXS 6.07%

CELC -4.25%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -1.01%

CERO -4.50%

CEROW -10.18%

CFRX -27.95%

CGEM -2.50%

CGEN -3.31%

CGON -0.48%

CGTX -5.11%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 2.56%

CINGW 34.95%

CKPT -2.87%

CLBS -16.75%

CLDX -2.26%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.04%

CLSD 1.60%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -7.50%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -39.44%

CNST 0.00%

CNTA -0.67%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -2.83%

CORT 2.20%

COYA -1.46%

CPRX -0.99%

CRBP -1.88%

CRBU -4.83%

CRDF -2.21%

CRGX 1.28%

CRIS -0.38%

CRNX -5.86%

CRSP 0.93%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -0.65%

CTXR 2.03%

CUE 3.53%

CVAC -2.26%

CVKD -5.23%

CWBR 2.80%

CYAD -12.96%

CYCC 10.09%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.08%

CYTO -2.73%

DARE 6.41%

DAWN 0.52%

DBTX -0.81%

DBVT 4.44%

DFFN 10.28%

DICE 0.06%

DMAC 30.55%

DNLI -1.43%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.21%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.52%

EDSA -1.00%

EFTR 8.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.98%

ELOX 7.69%

ELTX -0.88%

ELVN -3.87%

ELYM 1.05%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 4.13%

ENTA -0.49%

ENTO -4.42%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -1.02%

ETON 1.68%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX -0.03%

EXAI -0.57%

EXEL -0.36%

EYEG -0.69%

EYEN 1.48%

EYPT -0.24%

FATE -7.80%

FBIO 0.59%

FBIOP 0.92%

FBLG -14.30%

FBRX -0.04%

FDMT -4.86%

FENC -0.97%

FGEN -5.56%

FHTX 2.10%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.58%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.31%

FULC -3.18%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -1.49%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.31%

GHRS -1.59%

GLMD -2.32%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.00%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.92%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -9.88%

GOVX 5.93%

GOVXW -49.04%

GPCR -6.49%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.08%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -1.14%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.38%

HOOK 0.80%

HOTH -2.70%

HOWL -2.14%

HRMY 0.85%

HRTX 2.46%

HSTO 0.00%

HUMA 1.32%

HUMAW -0.01%

IBRX -3.85%

ICCC 0.22%

ICPT 0.21%

ICU 16.48%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.94%

IFRX -1.85%

IGMS -0.15%

IKNA 0.60%

IKT 1.42%

IMAB -0.58%

IMCR -2.61%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.68%

INAB 0.00%

INBX 0.46%

INCY -0.86%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 3.01%

INO -2.20%

INSM -0.84%

INTS -2.75%

INVA 0.25%

INZY 0.92%

IOBT -11.42%

IONS 0.34%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -2.15%

IRON -2.54%

ISEE 0.38%

ITOS -1.50%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.05%

JANX -4.03%

JAZZ -0.74%

JNCE 0.00%

JSPR -6.11%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.95%

KDNY 0.22%

KMPH -0.34%

KNSA -2.84%

KNTE -0.38%

KOD -7.11%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.20%

KRRO -6.34%

KRTX 0.03%

KRYS -0.90%

KTRA 18.97%

KTTA 8.16%

KTTAW 0.92%

KURA -1.83%

KYMR -2.41%

KYTX -4.52%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.71%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.65%

LENZ -3.36%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.61%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -4.05%

LPTX -1.10%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 1.76%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -35.05%

LYRA 2.33%

MACK 0.10%

MBIO -9.29%

MBRX -1.72%

MCRB 1.76%

MDGL -2.53%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.97%

MGX -2.68%

MIRM -1.80%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -5.79%

MNKD -1.14%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.18%

MORF -3.86%

MREO -5.29%

MRKR 2.68%

MRNA -4.81%

MRNS -4.04%

MRSN -2.61%

MRTX -0.17%

MRUS 0.13%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.24%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.15%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.90%

NEXI 2.60%

NGM -1.28%

NGNE -2.03%

NKGN 5.88%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.57%

NLSP -2.82%

NLSPW 26.67%

NMRA -1.32%

NMTR -42.97%

NOVN -24.84%

NRBO 10.16%

NRIX -0.34%

NRSN -7.05%

NRSNW 0.00%

NRXP -4.09%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.13%

NTRBW -31.07%

NUVL -2.00%

NVAX -2.22%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -2.49%

OBSV 0.00%

OCEA 0.00%

OCGN 3.81%

OCS -1.02%

OCUL -2.21%

OCUP 1.96%

ODT -4.27%

OKYO 1.51%

OLMA -5.29%

OMER -1.03%

OMGA 5.00%

ONCO 5.04%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -2.07%

ORIC -3.56%

ORMP 15.09%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.44%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -6.75%

PBYI 1.69%

PCSA 0.00%

PCVX -0.34%

PDSB -2.53%

PEPG 0.27%

PGEN -3.03%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.10%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.63%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.00%

PRQR -0.01%

PRTA -2.65%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -0.97%

PTCT -0.28%

PTE -0.82%

PTGX -1.70%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.95%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.92%

RARE 1.10%

RCKT -7.76%

REGN -0.70%

RENB -3.42%

REPL -2.60%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.44%

RIGL -3.28%

RLAY -4.68%

RLMD 0.33%

RLYB 0.00%

RNA -0.58%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.03%

ROIVW 4.56%

RPHM 0.00%

RPRX -0.07%

RPTX -2.93%

RUBY 2.70%

RVLP -32.05%

RVMD -1.20%

RVMDW -30.00%

RVNC 2.35%

RVPH -1.58%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.46%

RYTM -6.51%

RYZB 0.02%

RZLT 1.68%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -4.06%

SAVA -0.31%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 0.00%

SCPS 0.00%

SEEL -4.48%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.03%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -7.05%

SLGL 4.00%

SLN -4.21%

SLNO -4.03%

SLRX 6.04%

SLS -2.58%

SMMT -2.99%

SNDX 0.87%

SNGX -4.52%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.32%

SPRC -4.17%

SPRO 0.30%

SRNE -34.00%

SRPT -1.44%

SRRA 0.00%

SRRK -2.79%

SRZN -2.45%

STAB 0.00%

STOK -5.09%

STRO -2.84%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.42%

SWTX 0.34%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -7.57%

TARS 0.06%

TBPH 0.60%

TCBP 2.73%

TCDA 0.00%

TCON -2.03%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.15%

TENX -1.27%

TERN -7.72%

TFFP -3.05%

TGTX -2.97%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -3.09%

TNGX -2.16%

TNXP -6.39%

TNYA -7.02%

TPST 2.87%

TRDA -3.93%

TRVI 1.15%

TRVN 2.92%

TSHA -24.34%

TSVT -2.80%

TTNP -9.27%

TVTX 0.63%

TYRA -7.01%

UBX -2.12%

UNCY -2.43%

URGN -1.00%

UTHR -0.39%

VACC 11.36%

VALN -2.89%

VAXX 90.91%

VBIV 0.78%

VBLT -8.77%

VCEL 0.09%

VCNX 10.35%

VCYT -1.23%

VERA -2.74%

VERU 0.79%

VERV -2.96%

VIGL 5.11%

VINC 1.62%

VIR 0.54%

VIRI -1.57%

VIRX 2.40%

VKTX -1.65%

VLON -13.04%

VNDA -2.20%

VOR -2.01%

VRCA -0.07%

VRDN -4.23%

VRNA -1.40%

VRPX 0.38%

VRTX 0.39%

VSTM -3.74%

VTGN -0.45%

VTVT -2.97%

VTYX -0.21%

VXRT -2.90%

VYGR -1.53%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.51%

XBIO 0.93%

XBIT 1.77%

XCUR 3.58%

XENE -2.81%

XERS 2.38%

XFOR 2.09%

XLO 2.00%

XLRN 0.00%

XNCR 0.47%

XOMA -3.57%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.51%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-10-09	Davis Brady	Buy	68 000	Option to purchase Common Stock
2023-10-09	Davis Brady	Buy	7 500	Option to purchase Common Stock
2023-10-09	Davis Brady	Buy	135 000	Option to purchase Common Stock
2024-01-12	Mendelson Daniel Newman	Buy	1 000	Common Stock
2024-01-11	Mendelson Daniel Newman	Buy	2 000	Common Stock

INSIDER POWER
90.14
Last 100 transactions
Buy: 1 237 465 \| Sell: 480 213

सहसंबंध (AI algo v.1.1b): Overvalued: -0.22% $4.95 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

Champions Oncology Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
OZEM	1
AEI	0.939
PEV	0.927
AUVI	0.91
SAGE	0.907
TACT	0.903
BSBK	0.903
HFBL	0.902
NLSP	0.899
EEIQ	0.899

10 सबसे अधिक नकारात्मक सहसंबंध
KALU	-0.93
WLDN	-0.921
COOP	-0.914
PWP	-0.913
PVAL	-0.913
QNST	-0.912
KNTK	-0.91
IPKW	-0.91
IMPPP	-0.91
DWLD	-0.909

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Champions Oncology Inc वित्तीय

Annual	2023
राजस्व:	$53.87M
सकल लाभ:	$24.34M (45.18 %)
EPS:	$-0.390

FY	2023
राजस्व:	$53.87M
सकल लाभ:	$24.34M (45.18 %)
EPS:	$-0.390

FY	2022
राजस्व:	$49.11M
सकल लाभ:	$25.48M (51.88 %)
EPS:	$0.0415

FY	2021
राजस्व:	$41.04M
सकल लाभ:	$19.59M (47.74 %)
EPS:	$0.0300

Financial Reports:

No articles found.

Champions Oncology Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Champions Oncology Inc

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.